For individuals with a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, or other Asian family origin, or Black African or African-Caribbean family origin) and at least one weight-related comorbidity, GLP-1 receptor agonists such as semaglutide (Wegovy) may be considered through specialist weight management services, subject to the specific criteria and treatment duration outlined in the relevant NICE technology appraisal
RHEUMATOID ARTHRITIS: HOW TO IDENTIFY THE SYMPTOMS AND SEEK EFFECTIVE TREATMENT Rheumatoid arthritis is marked by chronic inflammation, joint pain and flare-ups, the doctor noted, and those with higher body fat and BMIs face a greater risk of developing the condition
Psychiatry 55 , 501511
It has required a structural adaptation of workflows, verification processes, and patient communication strategies
She warned that some of the peptides prescribed came with known health risks because they stimulated growth factors
At Optimal Health Medical, conversations about peptide therapy are approached through medical evaluation, symptom review, medication and supplement review, lab-informed decision-making when appropriate, realistic expectations, safety education, and follow-up
